Kerecis

Kerecis develops fish-skin products to heal human wounds and tissue damage. Fish skin helps wounds and burns heal quickly because it is rich in Omega3. The product is FDA approved and reimbursed by Medicare.

Industries

Pharmaceutical

Headquarters

Ísafjörður, Iceland

Stage

Series D

Employees

51-200

Links

Org chart

G. Fertram Sigurjonsson
Founder, Chairman, President & CEO
Collapse
Mike Cadigan
Chief Financial Officer
Christopher Harte
Chief Operating Officer, Global Markets & Technologies
Steve Dibiasio
Chief Sales Officer
Klara Sveinsdottir
EVP, Product Life Cycle
Gunnar Johannsson
SVP, Research & Development
Gudmundur Oskarsson
SVP, Marketing & Products
Hilmar Kjartansson
Co-founder & VP, Clinical Development
Baldur Tumi Baldursson
Co-founder & Medical Director

Teams

View all

+6

Leadership Team

9 members

+2

CEO and Executive Team

5 members

Founding Team

3 members

Discover similar companies

Culta

Silver Spring, United States

The Huggard Consulting Group

Itzig, Luxembourg

Charlie Health

Seed • Bozeman, United States

Galectin Therapeutics

Post IPO Debt • Norcross, United States

Eloxx Pharmaceuticals

Grant • Waltham, United States

Florealis

Venture • Reykjavík, Iceland

Bayer

Leverkusen, Germany

Alvogen

Private Equity • Montville, United States

Novartis

Basel, Switzerland

Immatics

Post IPO Equity • Tübingen, Germany

Prescient Healthcare Group

Private Equity • Jersey City, United States

Takeda Pharmaceutical

Osaka, Japan

The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.